Stifel Financial enters its July 22 earnings print having recovered well on the month but trailing a broad peer-group rally — a gap that sets up a genuinely interesting question about whether the Street's cautiously positive tone holds through the result.
The stock closed at $74.97, up 7.5% on the week and 6% over the past month. That sounds solid until you look across the peer group. Raymond James gained 12.4% on the week. LPL Financial added 14.2%. Ameriprise rose 13.7%. Even Jefferies climbed 8.3%. Stifel is moving with the sector, but clearly not leading it — notable for a name the Street still formally endorses.
The positioning picture is about as relaxed as it gets. Short interest runs at just over 4% of free float, and while that figure has grown about 13% over the past month, it remains a modest absolute level. More telling is the borrow market: availability is effectively unlimited, with 152 million shares ready to lend against a short position of around 4.1 million. Borrowing costs are low at 0.57% — slightly above last week's level but broadly unremarkable. Options traders show no defensiveness either. The put/call ratio of 0.28 is fractionally below its 20-day average of 0.32, and the reading has dropped sharply from the 0.85–1.09 range that persisted through May. Taken together, this is a stock where neither the short-sellers nor the options market is making a strong directional statement going into earnings.
The Street's position is broadly constructive but has been marked down. UBS, the most active voice on this name recently, cut its target from $89 to $86 on Tuesday while holding a Buy rating — a trimming rather than a rethink. That target still implies roughly 15% upside from current levels. The consensus mean sits at $86.38. TD Cowen holds a more cautious Hold. Valuation remains undemanding: the price-to-earnings multiple is around 11x, up modestly over the past month, while price-to-book has drifted slightly. The factor score for analyst recommendation divergence ranks in the 93rd percentile — meaning Stifel's formal analyst skew toward Buy is unusually high relative to the broader market — while EPS momentum scores are softer, ranking in the 30th-to-39th percentile range. The market is being asked to pay for franchise quality and deal-flow optionality, not near-term estimate momentum.
The earnings history adds some texture. The most recent print, in June, was essentially a non-event — the stock moved less than 0.2% on the day, then rallied 5.6% over the subsequent five sessions. The April print was different: the stock fell 6.5% on the day and continued dropping through the week. That divergence in same-day reaction suggests the result itself is hard to read in advance; the post-print drift matters more. Institutional positioning is stable and concentrated in index-oriented holders, with BlackRock at 9.4% and Vanguard entities together around 9%. AQR added 4.1 million shares as of March-end, a notable build for a quant shop — though that data is a quarter old.
With Q2 results due July 22, the focus falls on whether capital markets revenue has recovered enough to offset any softness in wealth management, and whether the company can narrow the relative-performance gap versus faster-moving peers like LPLA and RJF that have re-rated more aggressively this week.
See the live data behind this article on ORTEX.
Open SF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
